Abbott实验室符合Q2收入估计数,将2025财政年度EPS指导设定为5.10至5.20美元之间。 Abbott Labs meets Q2 earnings estimates, sets FY 2025 EPS guidance between $5.10-$5.20.

Abbott实验室报告第二季度收入为每股1.26美元,会议估计,收入为11.14亿美元。 Abbott Laboratories reported second-quarter earnings of $1.26 per share, meeting estimates, with revenue at $11.14 billion. 国家公园公司减少了9 998份股份,现在拥有227 790份股份,而南方信托公司增加了468份股份。 Park National Corp reduced its holdings by 9,998 shares, now owning 227,790 shares, while Trust Co of the South increased its holdings by 468 shares. LVM 资本管理公司也减少了其持有量。 LVM Capital Management also reduced its holdings. Abbott将2025财政年度EPS指南设定为5.100-5.200和Q3 2025年度EPS指南设定为1.280-1.320。 Abbott has set FY 2025 EPS guidance at 5.100-5.200 and Q3 2025 EPS guidance at 1.280-1.320.